1. A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report. Issue 2 (14th January 2022) Authors: Hamada, Kazuyuki; Yoshimura, Kiyoshi; Oshinomi, Kazuhiko; Hirasawa, Yuya; Ariizumi, Hirotsugu; Ohkuma, Ryotaro; Shida, Midori; Kubota, Yutaro; Matsui, Hiroto; Ishiguro, Tomoyuki; Sambe, Takehiko; Ishida, Hiroo; Horiike, Atsushi; Wada, Satoshi; Iwamoto, Sanju; Uchida, Naoki; Ogawa, Yoshio; Kobayas... Editors: Saranathan., Maya Journal: Medicine Issue: Volume 101:Issue 2(2022) Page Start: e28339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report. Issue 2 (14th January 2022) Authors: Hamada, Kazuyuki; Yoshimura, Kiyoshi; Oshinomi, Kazuhiko; Hirasawa, Yuya; Ariizumi, Hirotsugu; Ohkuma, Ryotaro; Shida, Midori; Kubota, Yutaro; Matsui, Hiroto; Ishiguro, Tomoyuki; Sambe, Takehiko; Ishida, Hiroo; Horiike, Atsushi; Wada, Satoshi; Iwamoto, Sanju; Uchida, Naoki; Ogawa, Yoshio; Kobayas... Other Names: Saranathan. Maya section editor. Journal: Medicine Issue: Volume 101:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy. Issue 23 (11th June 2021) Authors: Hirasawa, Yuya; Yoshimura, Kiyoshi; Matsui, Hiroto; Kubota, Yutaro; Ishida, Hiroo; Arai, Jun; Sakaki, Masashi; Oguro, Nao; Shida, Midori; Taniguchi, Makoto; Hamada, Kazuyuki; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Ohkuma, Ryotaro; Sambe, Takehiko; Horiike, Atsushi; Imamura, Chiyo K.; Shiozawa, ... Other Names: Saranathan. Maya section editor. Journal: Medicine Issue: Volume 100:Issue 23(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study). (February 2021) Authors: Tanzawa, Shigeru; Ushijima, Sunao; Shibata, Kazuhiko; Shibayama, Takuo; Bessho, Akihiro; Kaira, Kyoichi; Misumi, Toshihiro; Shiraishi, Kenshiro; Matsutani, Noriyuki; Tanaka, Hisashi; Inaba, Megumi; Haruyama, Terunobu; Nakamura, Junya; Kishikawa, Takayuki; Nakashima, Masanao; Iwasa, Keiichi; Fujiw... Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis. (December 2022) Authors: Tanaka, Hisashi; Tanzawa, Shigeru; Misumi, Toshihiro; Makiguchi, Tomonori; Inaba, Megumi; Honda, Takeshi; Nakamura, Junya; Inoue, Koji; Kishikawa, Takayuki; Nakashima, Masanao; Fujiwara, Keiichi; Kohyama, Tadashi; Ishida, Hiroo; Kuyama, Shoichi; Miyazawa, Naoki; Nakamura, Tomomi; Miyawaki, Hirosh... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer. (March 2016) Authors: Hirose, Takashi; Fujita, Ken-ichi; Kusumoto, Sojiro; Oki, Yasunari; Murata, Yasunori; Sugiyama, Tomohide; Ishida, Hiroo; Shirai, Takao; Nakashima, Masanao; Yamaoka, Toshimitsu; Okuda, Kentaro; Ohmori, Tohru; Sasaki, Yasutsuna Journal: Lung cancer Issue: Volume 93(2016) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer. (March 2016) Authors: Hirose, Takashi; Fujita, Ken-ichi; Kusumoto, Sojiro; Oki, Yasunari; Murata, Yasunori; Sugiyama, Tomohide; Ishida, Hiroo; Shirai, Takao; Nakashima, Masanao; Yamaoka, Toshimitsu; Okuda, Kentaro; Ohmori, Tohru; Sasaki, Yasutsuna Journal: Lung cancer Issue: Volume 93(2016) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan. Issue 1 (December 2016) Authors: Takata, Kosuke; Fujita, Ken-ichi; Kubota, Yutaro; Ishida, Hiroo; Ichikawa, Wataru; Shimada, Ken; Sekikawa, Takashi; Taki-Takemoto, Iori; Kamei, Daisuke; Iwai, Shinichi; Sasaki, Yasutsuna Journal: Journal of pharmaceutical health care and sciences Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Crizotinib-induced pancreatic pseudocyst: a novel adverse event. (8th September 2015) Authors: Ishida, Hiroo; Ichikawa, Wataru; Sasaki, Yasutsuna Journal: BMJ case reports Issue: Volume 2015 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Final report on plasma ctDNA T790M monitoring during EGFR-TKI treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial). (22nd March 2022) Authors: Naka, Go; Yokoyama, Takuma; Usui, Kazuhiro; Ishida, Hiroo; Kishi, Kazuma; Uemura, Kohei; Ohashi, Yasuo; Kunitoh, Hideo Journal: Japanese journal of clinical oncology Issue: Volume 52:Number 7(2022) Page Start: 783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗